Fifth Third Bancorp’s Veradermics Inc MANE Stock Holding History

Fifth Third Bancorp’s Portfolio MANE Stock Details MANE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.67M	Buy	+21,690	New	+$2.03M	﹤0.01%	1119

Other funds holding MANE

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

FMI

F/M Investments Washington, District of Columbia $1.97B AUM 30.33% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Fifth Third Bancorp's MANE Position: Q2 2026 in Review

Fifth Third Bancorp opened a new position in Veradermics Inc (MANE) in Q2 2026: 21,690 shares worth $2.67M. The stake represents ﹤0.01% of the portfolio and ranks #1119 among its holdings.

31 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

Fifth Third Bancorp held 21,690 shares of Veradermics Inc worth $2.67M as of Q2 2026.
Veradermics Inc was a new Fifth Third Bancorp position in Q2 2026.
Veradermics Inc made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1119 holding.
31 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.